MICCN researcher awarded prestigious Career Development Fellowship for investigation into Addiction
Monash Institute of Cognitive and Clinical Neurosciences (MICCN) researcher, Dr Adrian Carter, has been awarded a National Health and Medical Research Council (NHMRC) Career Development Fellowship so that he may continue his important research in addiction.
Alcohol, tobacco and illicit drug addiction continue to be the largest preventable cause of disease burden in Australia. However, the range of activities regarded as addictive is growing. Gambling and food consumption leading to obesity are now also regarded as addictions, with both costing Australia billions of dollars each year. Internet and sex addiction also cannot be ignored.
Prominent neuroscientists believe that neuroscience research will drastically reverse this growing epidemic and reduce the stigma and discrimination associated with addiction. However, there has been little neuroethical research examining the impact of neurobiological views of addictive behaviour on treatment and policy.
Dr Carter believes that society needs to consider the consequence of misuse or misrepresentation of neuroscience if we are to realise its promises while minimising social harm. As such, he leads an internationally recognised and multidisciplinary program examining the ethical and public health policy implications of neuroscience research on addictive behaviours.
Should we be taking a more therapeutic approach to addiction? Will society become more sympathetic to those with an addiction if they believed that addiction to be a disease? How would addicted people themselves feel about this - how would they react? Would they embrace the help, or consider themselves to be incurable? These are some of the areas that Dr Carter and his team will explore through the NHMRC Career Development Fellowship.
“The team and I are developing an Australian Neuroethics Network (ANN), to maximise the social and clinical benefits of neuroscience research on addictive behaviours“, said Dr Carter, who leads the neuroethics team at the Monash Biomedical Imaging facility as well as the neuroethics program for the Australia Research Council Centre of Excellence. “I am honoured to have received the NHMRC Career Development Fellowship so that we can effectively translate our important research into treatments and policies that are ethically effective whilst minimising social harm.”
MICCN congratulates Dr Carter on the award of his NHMRC Career Development Fellowship.
To speak with Dr Adrian Carter regarding his research into addiction, contact him on
t: 03 9902 9431, e: email@example.com.
Dr Adrian Carter